Pharmaceuticals
Healthcare
Drugmaker Akums hires banker for potential majority stake sale
Contract drug manufacturer Akums Drugs & Pharmaceuticals Ltd has hired a banker for a stake sale, three people familiar with ......
Healthcare
Kotak Private Equity scores a multi-bagger exit
Kotak Private Equity, the alternative investment arm of the country’s fourth biggest private lender Kotak Mahindra Bank, has struck an ......
Healthcare
Amanta Healthcare hires banker for fresh funding
Amanta Healthcare, formerly known as Marck Biosciences, has engaged an investment banker for its next round of funding that will ......
Healthcare
Baxter scouting for buyers for India intravenous business
US-based healthcare firm Baxter International, which lost out to Chinese conglomerate Fosun International in its bid for Gland Pharma, is ......
Healthcare
Mitra Biotech raises $27.4 mn from Sequoia, Sands Capital, others
Mitra Biotech Pvt. Ltd, which focuses on personalised cancer care and rational drug development, has raised $27.4 million in a ......
Healthcare
Aurobindo, Intas bid for Teva's products in Europe
Indian drugmakers Aurobindo Pharma and Intas Pharmaceuticals have submitted binding bids to acquire products from Israel’s Teva Pharmaceutical Industries in the ......
Pharmaceuticals
Taparia family buys majority stake in Guardian Lifecare
Taparia family, who sold contraceptive maker Famy Care to Mylan for $800 million last year, has acquired a majority stake ......
Healthcare
ChrysCapital explores exit from Eris Lifesciences
Private equity firm ChrysCapital is exploring options to exit Ahmedabad-based pharmaceutical company Eris Lifesciences Pvt. Ltd, two people familiar with ......
Healthcare
Carlyle, Bain, others eyeing Claris' injectables business
Private equity firm Carlyle Group will tie up with a drug maker to bid for the injectables drugs business of ......
Healthcare
Former Paras Pharma execs' firm buying into Chennai-based wellness startup
Athena Life Sciences Pvt. Ltd, founded by the former top executives of the erstwhile Paras Pharmaceuticals, has agreed to pick ......